{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:22:56Z","timestamp":1761060176313,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00228-016-2098-x","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T18:02:42Z","timestamp":1470247362000},"page":"1327-1334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese"],"prefix":"10.1007","volume":"72","author":[{"given":"Wu-Tao","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6988-5992","authenticated-orcid":false,"given":"Cheng-Hsun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"issue":"5","key":"2098_CR1","first-page":"706","volume":"30","author":"R Hu","year":"2014","unstructured":"Hu R, Xu Z, Zhao L-z et al (2014) Association of POR polymorphism and warfarin in stable maintenance dose in Han Chinese patient. Chin Pharmacol Bull 30(5):706\u2013710","journal-title":"Chin Pharmacol Bull"},{"issue":"10","key":"2098_CR2","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00228-013-1544-2","volume":"69","author":"SL Tan","year":"2013","unstructured":"Tan SL, Liz, Zhang W et al (2013) Cytochrome P450 oxidoreductase genetic polymorphism A503 and rs2868177 do not significantly affect warfarin in stable dosage in Han-Chinese patients with mechanical heart valve replacement. Eur J Clin Pharmacol 69(10):1769\u20131775","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"2098_CR3","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1530\/EJE-10-0764","volume":"163","author":"D Tomalik-Scharte","year":"2010","unstructured":"Tomalik-Scharte D, Malter D, Kirchheiner J et al (2010) Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency [J]. Eur J Endocrinol 163(6):919\u2013924","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2098_CR4","first-page":"820","volume":"17","author":"H Lei","year":"2012","unstructured":"Lei H, Li-Chen G et al (2012) Advances of pharmacogenomics of cytochrome P450 oxidoreductase. Chin J Clin Pharmacol Ther 17(7):820\u2013827","journal-title":"Chin J Clin Pharmacol Ther"},{"key":"2098_CR5","first-page":"470","volume":"12","author":"LS Kaminsky","year":"1984","unstructured":"Kaminsky LS, Dunbar DA, Wang PP, Beaune P, Larrey D, Guengerich FP, Schnellmann RG, Sipes IG (1984) Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin. Drug Metab Dispos 12:470\u2013477","journal-title":"Drug Metab Dispos"},{"key":"2098_CR6","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1124\/dmd.111.038836","volume":"39","author":"X Zhang","year":"2011","unstructured":"Zhang X (2011) Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose. Drug Metab Dispos 39:1433\u20131439","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"2098_CR7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/pgs.09.7","volume":"10","author":"AM Gomes","year":"2009","unstructured":"Gomes AM, Winter S, Klein K et al (2009) Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation [J]. Pharmacogenomics 10(4):579\u2013599","journal-title":"Pharmacogenomics"},{"issue":"1","key":"2098_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/FPC.0b013e3282f2f121","volume":"18","author":"SN Hart","year":"2008","unstructured":"Hart SN, Wang S, Nakamoto K et al (2008) Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism. Pharmacogenet Genomics 18(1):11\u201324","journal-title":"Pharmacogenet Genomics"},{"key":"2098_CR9","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1210\/jc.2008-0304","volume":"93","author":"LG Gomes","year":"2008","unstructured":"Gomes LG, Huang N, Agrawal V et al (2008) The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency. J Clin Endocrinol Metab 93:2913\u20132916","journal-title":"J Clin Endocrinol Metab"},{"key":"2098_CR10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mce.2008.09.017","volume":"300","author":"WL Miller","year":"2009","unstructured":"Miller WL, Huang N, Agrawal V et al (2009) Genetic variation in human P450 oxidoreductase. Mol Cell Endocrinol 300:180\u2013184","journal-title":"Mol Cell Endocrinol"},{"key":"2098_CR11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","volume":"21","author":"FP Guengerich","year":"2008","unstructured":"Guengerich FP (2008) Cytochrome p450 and chemical toxicology. Chem Res Toxicol 21:70\u201383","journal-title":"Chem Res Toxicol"},{"key":"2098_CR12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.mce.2010.10.022","volume":"336","author":"WL Miller","year":"2011","unstructured":"Miller WL, Agrawal V, Sandee D et al (2011) Consequences of POR mutations and polymorphisms. Mol Cell Endocrinol 336:174\u2013179","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2098_CR13","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1073\/pnas.0711621105","volume":"105","author":"H Lu","year":"2008","unstructured":"Lu H, Agrawal V et al (2008) Genetics of P450 oxidoreductase: sequences variation in 842 individuals of four ethnicities and activities of 15 missense mutations. Proc Nat Acad Sci USA 105(5):1733\u20131738","journal-title":"Proc Nat Acad Sci USA"},{"key":"2098_CR14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa0809329","volume":"360","author":"TE Klein","year":"2009","unstructured":"Klein TE, Altman RB, Eriksson N, Gage BF, Kimmel SE, Lee MT, Limdi NA, Page D, Roden DM, Wagner MJ, Caldwell MD, Johnson JA (2009) Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med 360:753\u2013764","journal-title":"N Engl J Med"},{"key":"2098_CR15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2125.2010.03698.x","volume":"70","author":"HJ Cen","year":"2010","unstructured":"Cen HJ, Zeng WT, Leng XY, Huang M, Chen X, Li JL, Huang ZY, Bi HC, Wang XD, He YL, He F, Zhou RN, Zheng QS, Zhao LZ (2010) CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement. Br J Clin Pharmacol 70:234\u2013240","journal-title":"Br J Clin Pharmacol"},{"key":"2098_CR16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clpt.2005.11.011","volume":"79","author":"CL Aquilante","year":"2006","unstructured":"Aquilante CL, Langaee TY, Lopez LM, Yarandi HN, Tromberg JS, Mohuczy D, Gaston KL, Waddell CD, Chirico MJ, Johnson JA (2006) Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements. Clin Pharmacol Ther 79:291\u2013302","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"2098_CR17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","volume":"17","author":"D Bois Du","year":"1916","unstructured":"Du Bois D, Du Bois EF (1916) A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17(6):863\u2013871","journal-title":"Arch Intern Med"},{"issue":"5","key":"2098_CR18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.fsigen.2012.01.002","volume":"6","author":"S Witt","year":"2012","unstructured":"Witt S, Neumann J et al (2012) Establishing a novel automated magnetic bead-based method for the extraction of DNA from a variety of forensic samples. Forensic Sci Int Genet 6(5):539\u2013547","journal-title":"Forensic Sci Int Genet"},{"key":"2098_CR19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/FPC.0b013e32832af5b7","volume":"19","author":"SC Sim","year":"2009","unstructured":"Sim SC, Miller WL, Zhong XB, Arlt W, Ogata T, Ding X, Wolf CR, Fluck CE, Pandey AV, Henderson CJ et al (2009) Nomenclature for alleles of the cytochrome P450 oxidoreductase gene. Pharmacogenet Genomics 19:565\u2013566","journal-title":"Pharmacogenet Genomics"},{"key":"2098_CR20","unstructured":"BGI-Tech. Sequenom MassArray procedures. http:\/\/www.genomics.cn\/navigation\/show_navigation?nid=220"},{"issue":"2","key":"2098_CR21","first-page":"219","volume":"26","author":"Q-S Zheng","year":"2012","unstructured":"Zheng Q-S, Zhao L-Z, Zeng W-T et al (2012) Impact of NR1I2 polymorphisms on warfarin maintenance dose and its inter-individual variation. Chin J Pharmacol Toxicol 26(2):219\u2013224","journal-title":"Chin J Pharmacol Toxicol"},{"key":"2098_CR22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/FPC.0b013e32833225e7","volume":"19","author":"B Oneda","year":"2009","unstructured":"Oneda B, Crettol S, Jaquenoud Sirot E et al (2009) The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test. Pharmacogenet Genomics 19:877\u2013883","journal-title":"Pharmacogenet Genomics"},{"key":"2098_CR23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/FPC.0b013e32833f4f9b","volume":"20","author":"D Sandee","year":"2010","unstructured":"Sandee D, Morrissey K, Agrawal V et al (2010) Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro. Pharmacogenet Genomics 20:677\u2013686","journal-title":"Pharmacogenet Genomics"},{"issue":"12","key":"2098_CR24","first-page":"1326","volume":"11","author":"J Yang","year":"2006","unstructured":"Yang J, Miao L-y (2006) Research advances in pharmacogenomics of warfarin. Chin J Clin Pharmacol Ther 11(12):1326\u20131331","journal-title":"Chin J Clin Pharmacol Ther"},{"key":"2098_CR25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tips.2009.05.001","volume":"30","author":"DE Jonas","year":"2009","unstructured":"Jonas DE, McLeod HL (2009) Genetic and clinical factors relating to warfarin dosing. Trends Pharmacol Sci 30:375\u2013386","journal-title":"Trends Pharmacol Sci"},{"key":"2098_CR26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ajhg.2007.10.002","volume":"82","author":"SA Scott","year":"2008","unstructured":"Scott SA, Edelmann L, Kornreich R, Desnick RJ (2008) Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations. Am J Hum Genet 82:495\u2013500","journal-title":"Am J Hum Genet"},{"key":"2098_CR27","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/hmg\/ddi180","volume":"14","author":"HY Yuan","year":"2005","unstructured":"Yuan HY, Chen JJ, Lee MT, Wung JC, Chen YF, Charng MJ, Lu MJ, Hung CR, Wei CY, Chen CH, Wu JY, Chen YT (2005) A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity. Hum Mol Genet 14:1745\u20131751","journal-title":"Hum Mol Genet"},{"issue":"7","key":"2098_CR28","first-page":"818","volume":"18","author":"L Huang","year":"2013","unstructured":"Huang L, Yang G-P (2013) Progress on influence of cytochrome P450 oxidoreductase polymorphism on cytochrome monooxygenases. Chin J Clin Pharmacol Ther 18(7):818\u2013823","journal-title":"Chin J Clin Pharmacol Ther"},{"issue":"1","key":"2098_CR29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2133\/dmpk.DMPK-10-SC-096","volume":"26","author":"Y Saito","year":"2011","unstructured":"Saito Y, Yamamoto N, Katori N, Maekawa K, Fukushima-Uesaka H, Sugimoto D, Kurose K, Sai K, Kaniwa N, Sawada J, Kunitoh H, Ohe Y, Yoshida T, Matsumura Y, Saijo N, Okuda H, Tamura T (2011) Genetic polymorphisms and haplotypes of por, encoding cytochrome p450 oxidoreductase, in a Japanese population. Drug Metab Pharmacokinet 26(1):107\u2013116","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"2098_CR30","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1073\/pnas.0711621105","volume":"105","author":"N Huang","year":"2008","unstructured":"Huang N, Agrawal V, Giacomini KM, Miller WL (2008) Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations. Proc Natl Acad Sci U S A 105(5):1733\u20131738","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2098_CR31","first-page":"1","volume":"0","author":"C Shen","year":"2015","unstructured":"Shen C, Huang X, Li J, Zhang P, Li L, Zhang W et al (2015) Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs. Xenobiotica 0:1\u201312","journal-title":"Xenobiotica"},{"key":"2098_CR32","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood-2008-04-149070","volume":"113","author":"M Wadelius","year":"2009","unstructured":"Wadelius M, Chen LY, Lindh JD, Eriksson N, Ghori MJ, Bumpstead S, Holm L, McGinnis R, Rane A, Deloukas P (2009) The largest prospective warfarin-treated cohort supports genetic forecasting. Blood 113:784\u2013792","journal-title":"Blood"},{"key":"2098_CR33","unstructured":"FDA (2007) FDA approves updated warfarin (Coumadin) prescribing information"},{"key":"2098_CR34","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","volume":"369","author":"JW Eikelboom","year":"2013","unstructured":"Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ et al (2013) Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 369:1206\u20131214","journal-title":"N Engl J Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2098-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-016-2098-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-016-2098-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:33Z","timestamp":1568246433000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-016-2098-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["2098"],"URL":"https:\/\/doi.org\/10.1007\/s00228-016-2098-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}